Cision PR Newswire

Zhang Ziyi: the new face of Clarins Precious

PARIS, Aug. 22, 2026 /PRNewswire/ -- Clarins is proud to announce Zhang Ziyi as Clarins Precious Global spokesperson. The Chinese actress, director and producer is a globally recognized...

ViewX Launches Liber and Immer Glasses-Free AI 3D Displays on Kickstarter

The new 15.6- and 27-inch Spatial AI displays combine on-display 3D processing, high-speed eye...

Ceretone and Easter Seals Greater Houston Bring Hearing Technology to Local Seniors Through Community Initiative

Organizations came together to help seniors use technology with confidence and shape the future...

Viettel Brings Two Decades of International Telecom Experience to the Dominican Republic

HANOI, Vietnam, Aug. 21, 2026 /PRNewswire/ -- Viettel Group, one of Vietnam's largest telecommunications...

WiMi’s Next-Generation Quantum Convolutional Neural Network Reshapes Classical Data Classification Methods

BEIJING, Aug. 21, 2026 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or...

Gauth Launches AI Course Feature to Transform Learning into Immersive Video Stories

SINGAPORE, July 31, 2026 /PRNewswire/ -- Gauth recently announced the launch of its groundbreaking AI Course feature, powered by Seedance 2.5, designed to revolutionize how...

Oxford International Digital Institute Launches Oxford ELLT Express to Support Time-Sensitive Student Applications

LONDON, July 31, 2026 /PRNewswire/ -- Oxford International Digital Institute (OIDI) has announced the launch of Oxford ELLT Express, a new service designed to...

Nippon Paint China Debuts at ARCHIDEX 2026, Showcasing Industrial Innovations

KUALA LUMPUR, Malaysia, July 31, 2026 /PRNewswire/ -- Nippon Paint China made its debut at ARCHIDEX 2026, held from July 29 to August 1...

“Hong Kong Cat Expo 2026” Opens Today

4-Metre-Tall Inflatable Gloomie Cowcat Arrives 400+ Booths Create a Summer Cat Carnival HONG KONG, July 31, 2026 /PRNewswire/ -- Organized by...

Ractigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy

RAG-1C achieves dual IND clearances from both U.S. FDA and China CDE, paving the way for global clinical development of the...